Jeffrey Stein, President & CEO at Cidara Therapeutics, Inc. (CDTX), bought 1,762 shares at $1.55 ($2K) on 2017-03-31, disclosed to the SEC on 2026-01-07.
Open-market purchase of $2k CDTX by President & CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.55 | 645 | $1000 | 41.8% |
| 2 | $1.19 | 750 | $892 | 37.3% |
| 3 | $1.36 | 367 | $498 | 20.9% |
| Total | $1.36 avg | 1,762 | $2K | 100% |
| Filing → |
| CDTX | BUY | 2023-08-08 | $48K | — | Filing → |
| CDTX | BUY | 2023-03-27 | $52K | — | Filing → |
| PRTK | SELL | 2023-02-23 | $13K | — | Filing → |